Liberal glucose targets for critically ill diabetic patients: is it time for large clinical trials with more personalized endpoints?

Affiliations

Comment

Judith Jacobi. Ann Transl Med. 2016 Sep.

. 2016 Sep;4(18):358.

doi: 10.21037/atm.2016.08.64.

¹ Critical Care Pharmacist, Indiana University Health Methodist Hospital, Indianapolis, IN, USA.

No abstract available

Conflict of interest statement

The author has no conflicts of interest to declare.

Liberal Glycemic Control in Critically Ill Patients With Type 2 Diabetes: An Exploratory Study.
Kar P, Plummer MP, Bellomo R, Jenkins AJ, Januszewski AS, Chapman MJ, Jones KL, Horowitz M, Deane AM. Kar P, et al. Crit Care Med. 2016 Sep;44(9):1695-703. doi: 10.1097/CCM.0000000000001815. Crit Care Med. 2016. PMID: 27315191

1. Jacobi J, Bircher N, Krinsley J, et al. Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients. Crit Care Med 2012;40:3251-76. 10.1097/CCM.0b013e3182653269 - DOI - PubMed
1. American Diabetes Association . Standards of medical care in diabetes--2012. Diabetes Care 2012;35 Suppl 1:S11-63. 10.2337/dc12-s011 - DOI - PMC - PubMed
1. Marik PE. Precision Glycemic Control in the ICU. Crit Care Med 2016;44:1433-4. 10.1097/CCM.0000000000001683 - DOI - PubMed
1. Falciglia M, Freyberg RW, Almenoff PL, et al. Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis. Crit Care Med 2009;37:3001-9. 10.1097/CCM.0b013e3181b083f7 - DOI - PMC - PubMed
1. Plummer MP, Bellomo R, Cousins CE, et al. Dysglycaemia in the critically ill and the interaction of chronic and acute glycaemia with mortality. Intensive Care Med 2014;40:973-80. 10.1007/s00134-014-3287-7 - DOI - PubMed